Vascular endothelial growth factor (VEGF) is one of the main angiogenic cytokines in human solid tumours and inhibition of VEGF-induced angiogenesis suppresses tumour growth. Some groups of malignant lymphoma, including peripheral T-cell lymphomas and Hodgkin's disease, are characterized by a conspi
Expression of vascular endothelial growth factor in dura mater of patients with moyamoya disease
β Scribed by Shigeyuki Sakamoto; Yoshihiro Kiura; Fumiyuki Yamasaki; Masaaki Shibukawa; Shinji Ohba; Prabin Shrestha; Kazuhiko Sugiyama; Kaoru Kurisu
- Publisher
- Springer-Verlag
- Year
- 2007
- Tongue
- English
- Weight
- 147 KB
- Volume
- 31
- Category
- Article
- ISSN
- 0344-5607
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract An increased capillary network has been observed in skeletal muscle of patients with restless legs syndrome (RLS) and obstructive sleep apnea syndrome (OSAS). This finding could be due to upregulation of growth factors responsible for angiogenesis. The aim of the study was to examine th
## BACKGROUND. Angiogenesis is essential for tumor growth and metastasis. Vascular endothelial growth factor (VEGF) and thymidine phosphorylase (TP)/platelet-derived endothelial cell growth factor (PD-ECGF) are involved in increased angiogenic activity and disease progression in solid tumors. Howev